PHOTO
National Bank of Fujairah JSC (NBF) announced today its collaboration with Royal Health Group, a healthcare group based in Abu Dhabi, through funding them with AED 50 million to curb the spread of the COVID-19 pandemic. The group provides a wide array of medical expertise in the UAE and beyond, where the funding was initiated towards better equipping them as a national response to the COVID-19 pandemic.
Royal Health Group has various healthcare provisions under its network, including specialised clinics, pharmacies, day surgeries, home care, and rehabilitation services. The funding was used to manage the operations of two Emergency COVID-19 hospitals, support mobile teams for regular PCR testing at various sites in the UAE, and assist the national vaccination campaign. These efforts combined will boost the national capacity and limit the spread of coronavirus cases.
Commenting on this, Rehan Ali, NBF’s Head of Business Banking, said: “NBF has always been known as the preferred financial partner for businesses in the UAE, and we strongly believe that we have a role to play in supporting various stakeholders to pave the road towards economic and societal recovery. In initiating AED 50 million worth of funding, we reiterate the importance of collaboration between banks and businesses in future-proofing our society and economy. We would like to congratulate and thank Royal Health Group for their efforts to assist stop the spread of the COVID-19 pandemic and usher us into a new normal.”
Speaking on behalf of Royal Health Group, Dr Mohammed AlSeiari, Chairman of Royal Heath Group, said: “Royal Heath Group, a well-recognised national healthcare group that is led by Emirati physicians, has been very effective in supporting UAE government’s fight against COVID-19 pandemic. With more than 1 million vaccination shots and 2 COVID-19 hospitals entrusted by the Department of Health, Royal Health Group became one of the major operators to fight against this pandemic during 2020-2021. Our partnership with NBF has been a major cornerstone to ensure the financial stability of the group’s medical operations.”
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
